Monoamine oxidase inhibitors (MAOIs) combined with kombucha, a fermented tea beverage, pose a significant risk of hypertensive crisis due to tyramine content in kombucha.
Tyramine levels in kombucha vary by brand, brewing method, and storage; even commercial varieties may pose risks.
All MAOIs (e.g., phenelzine, tranylcypromine, selegiline) carry this interaction potential; no safe threshold exists.
Patients should carry a medical alert identifying MAOI use and avoid self-prepared fermented products.
Monitor blood pressure regularly and report any unusual symptoms promptly.
MAOIs block the enzyme monoamine oxidase, which normally breaks down tyramine in the gut and liver. Kombucha, being fermented, can contain variable levels of tyramine, a biogenic amine that, when not metabolized, is absorbed and displaces stored norepinephrine from nerve terminals, leading to vasoconstriction and a sudden increase in blood pressure.
This interaction can cause hypertensive crisis, manifesting as severe headache, palpitations, nausea, vomiting, and potentially life-threatening complications like stroke, heart attack, or organ damage. Symptoms may occur within minutes to hours of consumption.
Strictly avoid kombucha and other tyramine-rich fermented foods/drinks while taking MAOIs. Consult a healthcare provider for dietary guidelines and alternatives. If accidental consumption occurs and symptoms arise, seek emergency medical attention immediately.
Was this helpful?
The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.
